However, in this study, Kaplan–Meier survival analysis showed that, while KRAS‐mutation(+) CRC showed significantly worse prognosis, NRAS‐mutation(+) CRC and oncogene‐mutation(−) CRC showed relatively better prognosis. The gene discussed is KRAS; the disease is colorectal carcinoma.